These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27455803)

  • 41. Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients.
    Fukushima T; Horike H; Fujiki S; Kitada S; Sasaki T; Kashihara N
    Ther Apher Dial; 2009 Jun; 13(3):213-9. PubMed ID: 19527468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
    Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
    Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Zinc and Kidney Disease: A Review.
    Abdollahi A; Ghahramani A; Ghahramani N
    Iran J Kidney Dis; 2022 Mar; 16(2):79-87. PubMed ID: 35489076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.
    Artunc F; Risler T
    Nephrol Dial Transplant; 2007 Oct; 22(10):2900-8. PubMed ID: 17556407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Zinc and deficiencies of taste and smell.
    Alpers DH
    JAMA; 1994 Oct; 272(16):1233-4. PubMed ID: 7933356
    [No Abstract]   [Full Text] [Related]  

  • 46. Improvement of uremic hypogeusia by zinc: a double-blind study.
    Mahajan SK; Prasad AS; Lambujon J; Abbasi AA; Briggs WA; McDonald FD
    Am J Clin Nutr; 1980 Jul; 33(7):1517-21. PubMed ID: 6772011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly.
    Agarwal AK
    J Am Med Dir Assoc; 2006 Nov; 7(9 Suppl):S7-S12; quiz S17-21. PubMed ID: 17098634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zinc and Taste Disturbances in Older Adults: A Review of the Literature.
    Pisano M; Hilas O
    Consult Pharm; 2016 May; 31(5):267-70. PubMed ID: 27178656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant human erythropoietin treatment protects the cardio-renal axis in a model of moderate chronic renal failure.
    Teixeira AM; Garrido P; Santos P; Alves R; Parada B; Costa E; Almeida A; Teixeira-Lemos E; Sereno J; Pinto R; Belo L; Santos-Silva A; Teixeira F; Reis F
    Ren Fail; 2010; 32(9):1073-80. PubMed ID: 20863212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of anaemia treatment for left ventricular remodelling prior to initiation of dialysis in chronic kidney disease patients: Efficacy and stability of long acting erythropoietin stimulating agents.
    Io H; Aizawa M; Funabiki K; Horikoshi S; Tomino Y
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():7-13. PubMed ID: 26439537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current management of renal anemia in patients with chronic kidney disease at the predialysis stage].
    Kuriyama S; Otsuka Y; Uetake D; Shirai I; Hosoya T
    Nihon Jinzo Gakkai Shi; 2007; 49(5):505-10. PubMed ID: 17695813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.
    Wagner M; Alam A; Zimmermann J; Rauh K; Koljaja-Batzner A; Raff U; Wanner C; Schramm L
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1573-9. PubMed ID: 21734083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anemia in renal insufficiency.
    Santoro A
    Rev Clin Exp Hematol; 2002; Suppl 1():12-20. PubMed ID: 12735211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dosing patterns and costs of erythropoietic agents in patients with chronic kidney disease not on dialysis in managed care organizations.
    Duh MS; Mody SH; Scott McKenzie R; Lefebvre P; Gosselin A; Tak Piech C
    Clin Ther; 2006 Sep; 28(9):1443-50. PubMed ID: 17062316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C.E.R.A. once every 4 weeks in patients with chronic kidney disease not on dialysis: The ARCTOS extension study.
    Kessler M; Martínez-Castelao A; Siamopoulos KC; Villa G; Spinowitz B; Dougherty FC; Beyer U
    Hemodial Int; 2010 Apr; 14(2):233-9. PubMed ID: 19888948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A; Makusidi AM; Kolo PM
    Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anemia and bone disease of chronic kidney disease: pathogenesis, diagnosis, and management.
    Shemin D
    R I Med J (2013); 2014 Dec; 97(12):24-7. PubMed ID: 25463623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: a retrospective cohort study.
    Nurko S; Spirko R; Law A; Dennis VW
    Clin Ther; 2007 Sep; 29(9):2010-21. PubMed ID: 18035200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Androgen versus erythropoietin for the treatment of anaemia of pre-dialysis chronic kidney disease.
    Paul AK; Latif ZA; Iqbal S; Amin F; Shefin SM; Ashrafuzzaman SM
    Mymensingh Med J; 2012 Jan; 21(1):125-8. PubMed ID: 22314467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of chronic kidney disease: what is the evidence?
    Brosnahan G; Fraer M
    South Med J; 2010 Mar; 103(3):222-30. PubMed ID: 20134375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.